Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

HRTX

Heron Therapeutics Inc

Dec 07 • 02:49PM ET

1.39

Dollar change -0.05
Percentage change -3.47	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.97	Insider Own	1.58%	Shs Outstand	150.07M	Perf Week	13.02%
Market Cap	208.61M	Forward P/E	-	EPS next Y	-0.38	Insider Trans	117.95%	Shs Float	147.71M	Perf Month	75.76%
Income	-119.70M	PEG	-	EPS next Q	-0.15	Inst Own	78.77%	Short Float / Ratio	11.91% / 5.98	Perf Quarter	7.76%
Sales	122.84M	P/S	1.70	EPS this Y	44.76%	Inst Trans	6.29%	Short Interest	17.59M	Perf Half Y	16.82%
Book/sh	-0.20	P/B	-	EPS next Y	58.54%	ROA	-47.77%	Target Price	5.62	Perf Year	-43.49%
Cash/sh	0.52	P/C	2.69	EPS next 5Y	47.50%	ROE	-2408.88%	52W Range	0.50 - 3.41	Perf YTD	-44.40%
Dividend	-	P/FCF	-	EPS past 5Y	14.46%	ROI	-80.22%	52W High	-59.23%	Beta	1.54
Dividend %	-	Quick Ratio	1.91	Sales past 5Y	44.61%	Gross Margin	44.77%	52W Low	178.02%	ATR	0.15
Employees	203	Current Ratio	2.43	Sales Q/Q	18.36%	Oper. Margin	-98.30%	RSI (14)	63.69	Volatility	12.64% 16.77%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	54.01%	Profit Margin	-97.45%	Rel Volume	0.47	Prev Close	1.44
Shortable	Yes	LT Debt/Eq	-	Earnings	Nov 14 AMC	Payout	-	Avg Volume	2.94M	Price	1.39
Recom	1.00	SMA20	26.42%	SMA50	52.97%	SMA200	-8.40%	Volume	1,152,616	Change	-3.47%

Date	Action	Analyst	Rating Change	Price Target Change
May-27-20	Initiated	Guggenheim	Buy	$24
Feb-20-20	Reiterated	Needham	Buy	$50 → $48
Jan-16-19	Reiterated	Needham	Buy	$66 → $64
Apr-05-18	Initiated	Evercore ISI	Outperform	$56
Mar-19-18	Reiterated	Mizuho	Buy	$28 → $35
Mar-01-18	Reiterated	Needham	Buy	$28 → $30
Jan-03-18	Initiated	Leerink Partners	Outperform	$22
Sep-27-17	Initiated	Northland Capital	Outperform	$40
Feb-27-17	Initiated	Needham	Buy	$28
Oct-26-16	Initiated	Aegis Capital	Buy
Sep-06-16	Resumed	Lake Street	Buy	$45
May-03-16	Initiated	Cantor Fitzgerald	Buy
Dec-10-15	Initiated	Lake Street	Buy	$45
Sep-23-15	Reiterated	Leerink Partners	Outperform	$38 → $57
Sep-02-15	Initiated	BofA/Merrill	Buy	$46
Aug-03-15	Reiterated	Brean Capital	Buy	$40 → $45
Jun-30-15	Reiterated	JMP Securities	Mkt Outperform	$25 → $33
Jun-19-15	Reiterated	Leerink Partners	Outperform	$26 → $38
Aug-07-14	Initiated	Noble Financial	Buy	$18

Show Previous Ratings

Dec-06-23 11:55AM	13 Hot Penny Stocks To Buy According to Hedge Funds (Insider Monkey)
Nov-28-23 07:33PM	Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth (InvestorPlace) -7.95%
Nov-15-23 10:17AM	Heron Therapeutics Inc (HRTX) Raises 2023 Sales Guidance and Projects Positive EBITDA in 2024 (GuruFocus.com) +59.26%
08:51AM	Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2023 Earnings Call Transcript (Insider Monkey)
08:46AM	Q3 2023 Heron Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
06:00PM	Loading…
Nov-14-23 06:00PM	Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
04:17PM	Heron Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance (PR Newswire)
Nov-07-23 04:05PM	Heron Therapeutics to Report Third Quarter 2023 Financial Results On Tuesday, November 14, 2023 (PR Newswire) +6.88%
Aug-24-23 09:29AM	11 Best Long-Term Penny Stocks to Buy Now (Insider Monkey)
Aug-15-23 01:30PM	Heron Therapeutics (HRTX) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks) +10.93%
12:48PM	Heron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2023 Earnings Call Transcript (Insider Monkey)
09:47AM	Q2 2023 Heron Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-14-23 04:29PM	Heron Therapeutics: Q2 Earnings Snapshot (Associated Press Finance) -6.79%
04:05PM	Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates (PR Newswire)
04:05PM	Loading…
Aug-07-23 04:05PM	Heron Therapeutics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023 (PR Newswire)
10:50AM	Insiders Pour Millions Into These 2 Stocks Under $10 Heres Why Wall Street Thinks They Could Double (or More) (TipRanks)
Jul-26-23 01:30PM	Northland Capital Markets Institutional Investor Conference (ACCESSWIRE) +9.27%
Jul-24-23 09:02AM	Heron Therapeutics Announces Cost Reduction Plan and Restructuring (PR Newswire) +11.59%
09:00AM	Heron Therapeutics Announces $30 Million Private Placement Financing (PR Newswire)
Jun-23-23 04:05PM	Heron Therapeutics Announces Appointment of Ira Duarte as Chief Financial Officer (PR Newswire)
Jun-12-23 09:00AM	Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer (PR Newswire)
May-11-23 05:15PM	Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -8.98%
04:12PM	Heron Therapeutics: Q1 Earnings Snapshot (AP Finance)
04:01PM	Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2023 and Highlights Recent Corporate Updates (PR Newswire)
May-05-23 12:28PM	Investors Don't See Light At End Of Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Tunnel (Simply Wall St.)
Apr-20-23 11:45AM	These 2 Growth Stocks Might Be Incredibly Undervalued Right Now (Motley Fool) -5.56%
09:00AM	Heron Therapeutics Announces Commercial Leadership Changes (PR Newswire)
Apr-17-23 04:05PM	Heron Therapeutics Announces Presentation at 22nd Annual Needham Virtual Healthcare Conference (PR Newswire) +5.13%
Apr-06-23 03:42PM	Why Heron Therapeutics Stock Has Been on Fire This Week (Motley Fool) +20.00%
02:01PM	Loading…
02:01PM	Why Shares of Heron Therapeutics Jumped Thursday (Motley Fool)
Apr-03-23 09:00AM	Heron Therapeutics Announces New CEO and Board Chairman (PR Newswire) +17.88%
Mar-27-23 07:12AM	Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2022 Earnings Call Transcript (Insider Monkey) -9.19%
Mar-24-23 06:43AM	Q4 2022 Heron Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -7.75%
Mar-23-23 09:28PM	Dow futures tick higher, banking crisis weighs (Investing.com)
05:35PM	Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Highlights Recent Corporate Updates (PR Newswire)
Mar-13-23 09:00AM	Heron Therapeutics Announces Centers for Medicare & Medicaid Services (CMS) Granted Pass-through Payment Status for APONVIE, Effective April 1, 2023 (PR Newswire) +11.11%
Mar-10-23 04:05PM	Heron Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 23, 2023 (PR Newswire) -5.68%
Mar-06-23 09:00AM	Heron Therapeutics Announces U.S. Commercial Launch of APONVIE for the Management of Postoperative Nausea and Vomiting in Adults (PR Newswire)
Feb-27-23 04:30PM	Heron Therapeutics Announces Presentation at 43rd Annual Cowen Healthcare Conference (PR Newswire)
Feb-22-23 09:00AM	Heron Therapeutics Enters into Cooperation Agreement with Rubric Capital and Velan Capital (PR Newswire) +10.88%
Jan-30-23 05:54AM	The past three years for Heron Therapeutics (NASDAQ:HRTX) investors has not been profitable (Simply Wall St.)
Jan-09-23 08:30AM	Heron Therapeutics Highlights Progress in Acute Care and Oncology Care Franchises (PR Newswire)
Dec-29-22 09:45AM	Heron Therapeutics Files For Expanded Use Of Zynrelef In Soft Tissue, Orthopedic Surgical Procedures (Benzinga) +9.78%
09:00AM	Heron Therapeutics Announces Filing of an Efficacy Supplement for ZYNRELEF® and Provision in Newly Passed Congressional Bill Anticipated to Provide Separate Reimbursement Outside of the Packaged Surgical Payment for ZYNRELEF (PR Newswire)
Dec-28-22 12:32PM	15 Most Shorted Stocks Hedge Funds Are Buying (Insider Monkey)
Dec-20-22 03:41PM	12 Best Affordable Stocks to Buy Under $5 (Insider Monkey)
Nov-21-22 04:05PM	Heron Therapeutics Announces Virtual Presentation at Evercore ISI 5th Annual HealthCONx Conference (PR Newswire)
Nov-15-22 10:14PM	7 Penny Stocks to Buy for 10-Bagger Returns (InvestorPlace)
Nov-10-22 05:44AM	Heron Therapeutics Third Quarter 2022 Earnings: In Line With Expectations (Simply Wall St.)
Nov-09-22 01:15PM	Analysts Cut Price Targets As Heron Therapeutics' Zynrelef Disappoints In Q3 (Benzinga) -12.75%
Nov-08-22 06:25PM	Heron Therapeutics (HRTX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2022 and Highlights Recent Corporate Updates (PR Newswire)
Nov-04-22 11:48AM	Hurry! 7 Pitiful Stocks to Sell Before 2022 Ends (InvestorPlace)
Nov-01-22 04:05PM	Heron Therapeutics to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022 (PR Newswire)
Sep-26-22 09:45AM	4 No-Brainer Penny Stocks to Buy if You Have Money to Invest (InvestorPlace)
Sep-23-22 09:19AM	10 Most Shorted Stocks in September (Insider Monkey) -7.66%
07:30AM	7 Unknown Biotech Stocks That Could Rocket in 2023 (InvestorPlace)
Sep-19-22 06:42AM	FDA Approves Heron Therapeutics' Post-Op Nausea Treatment (Benzinga)
Sep-16-22 02:49PM	Heron Therapeutics Announces U.S. FDA Approval of APONVIE (HTX-019) for the Prevention of Postoperative Nausea and Vomiting (PONV) (PR Newswire)
Sep-12-22 07:37AM	3 Stocks Expecting Good News From the FDA (Motley Fool)
Aug-23-22 12:00PM	All You Need to Know About Heron Therapeutics (HRTX) Rating Upgrade to Buy (Zacks)
Aug-15-22 09:55AM	How Much Upside is Left in Heron Therapeutics (HRTX)? Wall Street Analysts Think 91% (Zacks)
Aug-09-22 02:10PM	Heron Shares Jump After Equity Financing, Q2 Earnings (Benzinga) +15.13%
09:15AM	Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
08:01AM	Heron Therapeutics Announces $76.5 Million Private Placement Financing (PR Newswire)
08:00AM	Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2022 and Highlights Recent Corporate Updates (PR Newswire)
Aug-02-22 04:05PM	Heron Therapeutics to Report Second Quarter 2022 Financial Results on Tuesday, August 9, 2022 (PR Newswire)
Jul-21-22 06:32AM	Heron Therapeutics (NASDAQ:HRTX) shareholders have endured a 83% loss from investing in the stock three years ago (Simply Wall St.)
Jul-18-22 06:00PM	7 Biotech Stocks to Buy for Q3 (InvestorPlace)
Jun-30-22 08:41AM	Heron Therapeutics to cut about one-third of its workforce as part of cost-cutting plan (MarketWatch) -11.99%
08:30AM	Heron Therapeutics Announces Restructuring and Cost Reduction Plan to Address Market Dynamics and Prepare for Long-Term Sustainability (PR Newswire)
Jun-14-22 08:30AM	Heron Therapeutics Announces Publication Showing ZYNRELEF® as the Foundation of a Perioperative Non-Opioid Multimodal Analgesic Regimen Reduced Severe Pain and Opioid Use in Patients Undergoing Total Knee Arthroplasty (PR Newswire)
May-26-22 04:05PM	Heron Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference (PR Newswire)
May-16-22 04:05PM	Heron Therapeutics Presents ZYNRELEF® Data at the Society for Obstetric Anesthesia and Perinatology 54th Annual Meeting (PR Newswire)
May-09-22 06:45PM	Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -12.17%
04:05PM	Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Recent Corporate Updates (PR Newswire)
May-03-22 04:05PM	Heron Therapeutics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022 (PR Newswire)
Apr-05-22 04:05PM	Heron Therapeutics to Present at the 21st Annual Virtual Needham Healthcare Conference (PR Newswire)
Mar-28-22 03:14PM	Short Sellers Are Targeting These 10 Stocks (Insider Monkey)
Mar-25-22 08:30AM	Heron Therapeutics Secures Pass-through Payment Status for ZYNRELEF® from Centers for Medicare & Medicaid Services, Expanding Separate Reimbursement into the Hospital Outpatient Setting of Care (PR Newswire)
Mar-17-22 08:30AM	Heron Therapeutics Announces Approval of ZYNRELEF® by Health Canada for the Management of Postoperative Pain (PR Newswire) +7.02%
Mar-04-22 04:00PM	Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off. (Motley Fool) -5.35%
Mar-02-22 04:05PM	Heron Therapeutics to Present at 42nd Annual Cowen Healthcare Conference (PR Newswire)
Mar-01-22 03:38PM	Why Heron Therapeutics Stock Is Getting Hammered Today (Motley Fool) -18.94%
Feb-28-22 05:45PM	Heron Therapeutics (HRTX) Reports Q4 Loss, Lags Revenue Estimates (Zacks) -5.96%
04:05PM	Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2021 and Highlights Recent Corporate Updates (PR Newswire)
Feb-24-22 03:49PM	Short Sellers Were Right About These 10 Stocks (Insider Monkey) +8.31%
Feb-22-22 04:05PM	Heron Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28, 2022 (PR Newswire)
Feb-11-22 07:25AM	Strong week for Heron Therapeutics (NASDAQ:HRTX) shareholders doesn't alleviate pain of three-year loss (Simply Wall St.)
Feb-07-22 09:38AM	Twin Lakes Capital Management, LLC Buys Matterport Inc, DocuSign Inc, Teladoc Health Inc, Sells ... (GuruFocus.com)
Feb-02-22 01:38PM	Integral Health Asset Management, LLC Buys McKesson Corp, Centene Corp, Abbott Laboratories, ... (GuruFocus.com) -6.83%
Jan-19-22 01:38PM	Newbridge Financial Services Group, Inc. Buys Apple Inc, NVIDIA Corp, NXP Semiconductors NV, ... (GuruFocus.com)
Jan-03-22 09:38PM	Private Asset Management Inc Buys ASML Holding NV, Public Storage, Palantir Technologies Inc, ... (GuruFocus.com) +8.87%
Dec-09-21 04:19PM	Why Heron Therapeutics Shares Rose Nearly 15% This Week (Motley Fool) +11.38%
12:32PM	FDA Approves Indication Expansion For Heron Therapeutics' Post-Op Pain Med (Benzinga)
10:00AM	2 Short-Squeeze Candidates That Could Go Parabolic Soon (Motley Fool)
08:00AM	Heron Therapeutics Announces FDA Approval of a Significant Indication Expansion for ZYNRELEF® (PR Newswire)
Dec-06-21 01:42PM	10 Growth Stocks Under $20 in Billionaire Ken Fishers Portfolio (Insider Monkey)

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Forbes William P	EVP, Chief Development Officer	Nov 17	Buy	1.09	25,000	27,250	79,000	Nov 21 12:19 PM
Collard Craig A	Chief Executive Officer	Nov 16	Buy	0.92	150,000	137,970	186,496	Nov 17 12:37 PM
Duarte Ira	EVP, Chief Financial Officer	Nov 16	Buy	0.89	85,000	75,599	85,000	Nov 17 12:36 PM
Forbes William P	EVP, Chief Development Officer	Nov 16	Buy	0.94	50,000	46,995	54,000	Nov 20 10:07 AM
Morgan Adam	Director	Jul 21	Buy	1.37	2,486,744	3,406,839	6,986,744	Jul 25 04:22 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HRTX

Heron Therapeutics Inc

Upgrade your FINVIZ experience